Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000250321 is a pseudogene annotated as "pseudogene similar to part of ribosomal protein S17 (RPS17)". It does not code for a functional protein and is not considered a therapeutic or pharmacological target. Pseudogenes are generally non-functional gene sequences arising from gene duplication or retrotransposition, lacking the ability to produce a functional product. This particular entry is a non-coding remnant with partial sequence similarity to the RPS17 gene, encoding the 40S ribosomal protein S17—a small ribosomal subunit protein involved in protein synthesis. However, ENSG00000250321 itself does not play an active biological or pharmacological role. This is a pseudogene, not a functional gene or therapeutic target. No medications, mechanisms of action, biomarkers, or disease associations are relevant or reported for this pseudogene. This entry likely represents a case of misannotation or non-target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ribosomal protein S17.